Summary
IDEXX LABORATORIES, INC. (IDXX) filed an 8-K on December 12, 2017, to disclose amendments to its bylaws, effective December 6, 2017. The primary change is the implementation of proxy access, a significant governance update that allows eligible stockholders to nominate directors to the company's board. This new bylaw permits a stockholder or a group of up to 20 stockholders, holding at least 3% of the company's stock continuously for three years, to nominate director candidates. These nominees can constitute up to the greater of two individuals or 20% of the board's size, provided all requirements outlined in the amended bylaws are met. This move aligns with evolving corporate governance practices and provides shareholders with a greater voice in board composition.
Key Highlights
- 1IDEXX Laboratories, Inc. has amended its bylaws to implement proxy access.
- 2The proxy access provision allows eligible long-term stockholders to nominate director candidates.
- 3A stockholder or group of up to 20 stockholders must own at least 3% of outstanding common stock for at least three continuous years to utilize proxy access.
- 4Nominees under proxy access can represent up to the greater of two individuals or 20% of the board's size.
- 5The amendments also include minor, non-substantive changes and conform to the proxy access provision.
- 6The Amended Bylaws are effective as of December 6, 2017.
- 7The filing includes the Amended and Restated Bylaws as an exhibit.